Bifogade filer
New number of shares and votes in Q-linea AB (publ)
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
The number of shares and votes in Q-linea AB (publ) (the “Company”) has increased during February as a result of the rights issue of units resolved by the board of directors on November 5, 2024, with subsequent approval by the extraordinary general meeting on December 6, 2024, and the directed issue of 129,522,730 units resolved by the board of directors on February 10, 2025, with authorization.
As of February 28, 2025, the total number of shares in the Company amounts to 4,005,200,236 shares (previously 117,166,372 shares), with one vote each. All shares are common shares. The share capital amounts to SEK 200,260,011.80 (previously SEK 5,858,318.60). As of February 28, 2025, Q-linea AB holds 328,472 of its own shares.
Please note that the issues have been partially registered and the remaining 443,087,860 shares in the rights issue and the directed issue have not yet been registered and are therefore not included in this announcement. The remaining shares are subscribed by Ulf Landegren, through Landegren Gene Technology AB, are subject to notification to ISP. After the investment is left without action or approved by ISP, the number of shares in Q-linea will increase by 443,087,860, whereby the number of outstanding shares in Q-linea will amount to 4,448,288,096.